VitaNova Life Sciences Corp (VNOV) stock
Close on Oct 19, 2026Market cap $37.52MP/E –Yield –
VitaNova Life Sciences Corp grew revenue 22.0% to $3.24M over the twelve months to Jul 31, 2026. Operating income fell 107.1% to -$86.12K, moving the operating margin from 46.0% to -2.7%. At the latest close the market valued the company at $37.52M.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jul 31, 2026
Valuation
- Market cap
- $37.52M
- P/E ratio
- –
- Price to sales
- 11.57
- Price to book
- 19.46
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- $3.24M
- Net income
- -$114.10K
- EPS, diluted
- -$0.02
- Book value per share
- $0.23
- Diluted shares
- 8M
Trading
- Previous close
- $4.00
- Open
- $4.50
- Day's range
- $4.50 – $4.50
- Volume
- 200
- Average volume (20 days)
- 331
Market cap history
Month-end market cap since 2022, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Oct 19, 2026. The S&P 500 is measured by the SPY fund.
| Period | VNOV | S&P 500 | Difference | VNOV per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +226.1% | +0.6% | +225.5 pts | ||
| 3 months | +226.1% | +3.4% | +222.7 pts | ||
| Year to date | -6.8% | +13.3% | −20.1 pts | ||
| 1 year | -6.8% | +16.6% | −23.4 pts | ||
| 3 years | +150.0% | +86.4% | +63.6 pts | +35.7% | +23.1% |
Nine years at a glance
Fiscal years 2017 to 2026 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
About VitaNova Life Sciences
Wholesale-Apparel, Piece Goods & Notions
VitaNova Life Sciences Corporation is a consumer health, beauty, and lifestyle company that develops, acquires, markets, and sells branded nutritional supplements, functional beverages, and healthy food products. Its core consumer-health operations function under a dual-brand system comprising GeneCode, an advanced science-oriented wellness brand, and AMZ, a high-volume functional-nutrition line. The company also trades healthy food items such as olive juice, white sesame oil, and aloe vera drinks, while maintaining a business consulting segment that advises third parties on funding and management. It primarily serves consumers through a business-to-business model alongside regional distributors and online channels.
Company profile, executives and historyVitaNova Life Sciences stock: common questions
What is VitaNova Life Sciences's stock price?
VNOV closed at $4.50 on Oct 19, 2026, up 12.50% on the day.
What is VitaNova Life Sciences's market cap?
VitaNova Life Sciences was worth $37.52M at the close on Oct 19, 2026: the share price times the diluted shares outstanding.
What is VNOV's P/E ratio?
VitaNova Life Sciences lost money over the twelve months to Jul 31, 2026 (diluted EPS -$0.02), so it has no meaningful P/E ratio.
How much revenue does VitaNova Life Sciences make?
VitaNova Life Sciences reported revenue of $3.24M for the twelve months to Jul 31, 2026, up 22.0% from a year earlier.
Does VitaNova Life Sciences pay a dividend?
No. VitaNova Life Sciences has not paid a cash dividend over the last twelve months.
How has VNOV stock performed over the past year?
Including dividends, VNOV returned -6.8% over the past year, against +16.6% for the S&P 500.
Who are VitaNova Life Sciences's competitors?
Companies most similar to VitaNova Life Sciences by business, industry and size include STEK, BIOE, AHRO, BHIC, BNKK.
See a number that looks wrong?